Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104 USD | -0.27% | -0.13% | -5.56% |
05-23 | Medtronic beats quarterly profit estimates on medical devices strength | RE |
05-22 | Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B | |
-4.35% | 23.95B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott's Spinal Cord Simulation System Secures FDA Approval For Expanded Magnetic Resonance Imaging Compatibility